Hormonal modulation of the immune system - A spotlight on the role of progestogens

Autoimmunity Reviews

Volumn 14, Issue 6, 2015, Pages 536-542

  Tan, Irene J ^a   Peeva, Elena ^b   Zandman Goddard, Gisele ^c  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Autoimmunity; Gender; Immunomodulation; Multiple sclerosis; Progesterone; Progesterone receptor; Progestogens; Rheumatoid arthritis; Sex hormones; Synthetic progestins; Systemic lupus erythematosus; T cells

Indexed keywords

ESTROGEN; GESTAGEN; PROGESTERONE; SEX HORMONE;

ADAPTIVE IMMUNITY; AUTOIMMUNITY; DOSE RESPONSE; HORMONAL REGULATION; HORMONE METABOLISM; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; INNATE IMMUNITY; MULTIPLE SCLEROSIS; NONHUMAN; PREGNANCY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RHEUMATOID ARTHRITIS; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; X CHROMOSOME; ANIMAL; AUTOIMMUNE DISEASE; DRUG EFFECTS; IMMUNOLOGY; SEXUAL DEVELOPMENT;

ANIMALS; AUTOIMMUNE DISEASES; HUMANS; IMMUNE SYSTEM; PROGESTERONE; SEX CHARACTERISTICS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84933678863     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2015.02.004     Document Type: Review

References (83)

1. Shoenfeld Y., Selmi C., Zimlichman E., et al. The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity. J Autoimmun 2008, 31:325-330.
2. Whitacre C.C. Sex differences in autoimmune disease. Nat Immunol 2001, 2:777-780.
3. Hughes G.C. Progesterone and autoimmune disease. Autoimmun Rev 2012, 11:A502-A514.
4. Zandman-Goddard G., Peeva E., Shoenfeld Y. Gender and autoimmunity. Autoimmun Rev 2007, 6:366-372.
5. Danchenko N., Satia J.A., Anthony M.S. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus 2006, 15:308-318.
6. Peeva E. Reproductive immunology: a focus on the role of female sex hormones and other gender-related factors. Clin Rev Allergy Immunol 2011, 40:1-7.
7. Zandman-Goddard G., Peeva E. Connective tissue diseases: unraveling aetiology in male SLE-the X chromosome dose effect. Nat Rev Rheumatol 2012, 8:310-312.
8. Nussinovitch U., Shoenfeld Y. The role of gender and organ specific autoimmunity. Autoimmun Rev 2012, 11:A377-A385.
9. Nalbandian G., Kovats S. Understanding sex biases in immunity: effects of estrogen on the differentiation and function of antigen-presenting cells. Immunol Res 2005, 31:91-106.
10. McCombe P.A., Greer J.M., Mackay I.R. Sexual dimorphism in autoimmune disease. Curr Mol Med 2009, 9:1058-1079.
11. Enosawa S., Hirasawa K. Sex-associated differences in the survival of skin grafts in rats. Enhancement of cyclosporine immunosuppression in male compared with female recipients. Transplantation 1989, 47:933-937.
12. Ansar Ahmed S., Penhale W.J., Talal N.S. Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action. Am J Pathol 1985, 121:531-551.
13. Offner P.J., Moore E.E., Biffl W.L. Male gender is a risk factor for major infections after surgery. Arch Surg 1999, 134:935-938.
14. Latman N.S. Relation of menstrual cycle phase to symptoms of rheumatoid arthritis. Am J Med 1983, 74:957-960.
15. Lim G.S., Petri M., Goldman D. Menstruation and systemic lupus erythematosus: a case-controlled study. Arthritis Rheum 1993, 36(Suppl.5):R23. (abstract).
16. Nelson J.L., Ostensen M. Pregnancy and rheumatoid arthritis. Rheum Dis Clin N Am 1997, 23:195-212.
17. Confavreux C., Hutchinson M., Hours M.M., Cortinovis-Tourniaire P., Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in multiple sclerosis group. N Engl J Med 1998, 339:285-291.
18. Peeva E., Zouali M. Spotlight on the role of hormonal factors in the emergence of autoreactive B-lymphocytes. Immunol Lett 2005, 101:123-143.
19. Peeva E., Venkatesh J., Diamond B. Tamoxifen blocks estrogen-induced B cell maturation but not survival. Immunol Lett 2005, 175:1415-1423.
20. Cutolo M., Sulli A., Capellino S., et al. Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus 2004, 13:635-638.
21. Jaffe R.B. Biogenesis and metabolism of progesterone in the human fetus and placenta. Clin Obstet Gynecol 1967, 10:47-59.
22. Lee J.H., Ulrich B., Cho J., et al. Progesterone promotes differentiation of human cord blood fetal T cells into T regulatory cells but suppresses their differentiation into Th17 cells. J Immunol 2011, 187:1778-1787.
23. Hughes G.C., Clark E.A., Wong A.H. The intracellular progesterone receptor regulates CD4+ T cells and T cell-dependent antibody responses. J Leukoc Biol 2013, 93:369-375.
24. Druckmann R., Druckmann M.A. Progesterone and the immunology of pregnancy. J Steroid Biochem Mol Biol 2005, 97:389-396.
25. Stanczyk F.Z. All progestins are not created equal. Steroids 2003, 68:879-890.
26. Szekeres-Bartho J., Barakonyi A., Par G., et al. Progesterone as an immunomodulatory molecule. Int Immunopharmacol 2001, 1:1037-1048.
27. Dosiou C., Hamilton A.E., Pang Y., et al. Expression of membrane progesterone receptors on human T lymphocytes and Jurkat cells and activation of G proteins by progesterone. J Endocrinol 2008, 196:67-77.
28. Szekeres-Bartho J., Szekeres G., Debre P., et al. Reactivity of lymphocytes to a progesterone receptor-specific monoclonal antibody. Cell Immunol 1990, 125:273-283.
29. Tanriverdi F., Silveira L.F., MacColl G.S., et al. The hypothalamic-pituitary-gonadal axis: immune function and autoimmunity. J Endocrinol 2003, 176:293-304.
30. Beagley K.W., Gockel C.M. Regulation of innate and adaptive immunity by the female sex hormones oestradiol and progesterone. FEMS Immunol Med Microbiol 2003, 38:13-22.
31. Gulliver S.C. Sex steroids as inflammatory regulators. J Steroid Biochem Mol Biol 2010, 120:1-15.
32. Rubtsov A.V., Rubtsova K., Kappler J.W., et al. Genetic and hormonal factors in female-biased autoimmunity. Autoimmun Rev 2010, 9:494-498.
33. Kang Y., Li G., Mao G., et al. Progesterone increases systemic and local uterine proportions of CD4CD25+ Treg cells during midterm pregnancy in mice. Endocrinol 2010, 151:5477-5488.
34. Hughes G.C., Clark E.A. Regulation of dendritic cells by female sex steroids: relevance to immunity and autoimmunity. Autoimmunity 2007, 40:470-481.
35. Vermeulen M., Pazos P., Lanari C., et al. Medroxyprogesterone acetate enhances in vivo and in vitro antibody production. Immunol 2001, 104:80-86.
36. Mosmann T.R., Cherwinski H., Bond M.W., et al. Two types of murine helper T cell clones I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986, 136:2348-2356.
37. Peck A., Mellins E.D. Plasticity of T-cell phenotype and function: the T helper type example. Immunol 2009, 129:147-153.
38. Crome S.Q., Wang A.Y., Levings M.K. Translational mini-review series on Th17 cells: function and regulation of human T helper 17 cells in health and disease. Clin Exp Immunol 2010, 159:109-119.
39. Sakaguchi S. Naturally arising Foxp3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005, 6:345-352.
40. Akbar A.N., Vukmanovic-Stejic M., Taams L.S., et al. The dynamic co-evolution of memory and regulatory CD4+ T cells in the periphery. Nat Rev Immunol 2007, 7:231-237.
41. Saito S. Cytokine network at the feto-maternal interface. J Reprod Immunol 2000, 47:87-103.
42. Wegmann T.G., Lin H., Guilbert L., et al. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon?. Immunol Today 1993, 14:353-356.
43. Garzia E., Clauser R., Persani L., et al. Prolactin and proinflammatory cytokine expression at the fetomaternal interface in first trimester miscarriage. Fertil Steril 2013, 100:108-115.
44. Saito S., Nakashima A., Shima T., et al. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am J Reprod Immunol 2010, 63:601-610.
45. Piccinni M.P., Beloni L., Livi C., et al. Defective production of both leukemia inhibitory factor and type 2T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nat Med 1998, 4:1020-1024.
46. Marzi M., Vigano A., Trabattoni D., et al. Characterization of type 1 and type 2 cytokine production profiles in physiologic and pathologic human pregnancy. Clin Exp Immunol 1996, 106:127-133.
47. Piccinni M.P., Giudizi M.G., Biagiotti R., et al. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J Immunol 1995, 155:128-133.
48. Lee J.H., Lydon J.P., Kim C.H. Progesterone suppresses the mTOR pathway and promotes generation of induced regulatory T cells with increased stability. Eur J Immunol 2012, 42:1-14.
49. Cutolo M., Capellino S., Sulli A., et al. Estrogen and autoimmune diseases. Ann N Y Acad Sci 2006, 1089:538-547.
50. Gilmore W., Weiner L.P., Correale J. Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients with normal control subjects. J Immunol 1997, 158:446-451.
51. Koubovec D., Ronacher K., Stubsrud E., et al. Synthetic progestins used in HRT have different glucocorticoid agonist properties. Mol Cell Endocrinol 2005, 242:23-32.
52. Ishida Y., Mine T., Taguchi T. Effects of progestins with different glucocorticoid activity on bone metabolism. Clin Endocrinol 2008, 68:423-428.
53. Kastner P., Krust A., Turcotte B., et al. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J 1990, 9:1603-1614.
54. Zandman-Goddard G., Solomon M., Rosman Z., Peeva E., Shoenfeld Y. Environment and lupus-related diseases. Lupus 2012, 21:241-250.
55. Buyon J.P., Petri M.A., Kim M.Y., et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med 2005, 142:953-962.
56. Cravioto M.D.C., Durand-Carbajal M., Jimenez-Santana L., et al. Efficacy of estrogen plus progestin on menopausal symptoms in women with systemic lupus erythematosus: a randomized, double-blind, controlled trial. Arthritis Care Res 2011, 63:1654-1663.
57. Sammaritano L.R. Therapy insight: guidelines for selection of contraception in women with rheumatic diseases 2007, 3:273-281.
58. Clowse M.E.B. Managing contraception and pregnancy in the rheumatologic diseases. Best Pract Res Clin Rheumatol 2010, 24:373-385.
59. Petri M., Kim M.Y., Kalunian K.C., et al. Combined oral contraceptives in women with systemic lupus erythematosis. N Engl J Med 2005, 353:2550-2558.
60. Sanchez-Guerrero J., Uribe A.G., Jimenez-Santana L., et al. A trial of contraceptive methods in women with systemic lupus erythematosis. N Engl J Med 2005, 353:2539-2549.
61. Siiteri P.K., Febres F., Clemens L.E., et al. Progesterone and maintenance of pregnancy: is progesterone nature's immunosuppressant?. Ann NY Acad Sci 1977, 286:384-397.
62. Junger P., Dougados M., Pelissier C., et al. Influence of oral contraceptive therapy on the activity of systemic lupus erythematosis. Arthritis Rheum 1982, 25:618-623.
63. Mok C.C., Lau C.S. Pathogenesis of systemic lupus erythematosus. J Clin Pathol 2003, 56:481-490.
64. Pennell L.M., Galligan C.L., Fish E.N. Sex affects immunity. J Autoimmun 2012, 38:J282-J291.
65. Doria A., Cutolo M., Ghirardello A., et al. Steroid hormones and disease activity during pregnancy in systemic lupus erythematosus. Arthritis Rheum 2002, 47:202-209.
66. Baechler E.C., Batliwalla F.M., Karypis G., et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 2003, 100:2610-2615.
67. Yasuda K., Richez C., Maciaszek J.W., et al. Murine dendritic cell type I IFN production induced by human IgG-RNA immune complexes is IFN regulatory factor (IRF)5 and IRF7 dependent and is required for IL-6 production. J Immunol 2007, 178:6876-6885.
68. Feng D., Stone R.C., Eloranta M.L., et al. Genetic variants and disease-associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosus. Arthritis Rheum 2010, 62:562-573.
69. Hughes G.C., Thomas S., Li C., et al. Cutting edge: progesterone regulates IFN-α production by plasmacytoid dendritic cells. J Immunol 2008, 180:2029-2033.
70. Cao W., Liu Y. Innate immune functions of plasmacytoid dendritic cells. Curr Opin Immunol 2007, 19:24-30.
71. Ansar Ahmed S., Talal N., Wallace D.J., et al. Importance of sex hormones in systemic lupus erythematosus. Dubois' lupus erythematosus 1993, 148-156. Lea and Febiger, Philadelphia, PA. D. Wallace, B. Hahn (Eds.).
72. Spector T.D. Rheumatoid arthritis. Rheum Dis Clin North Am 1990, 16:513-537.
73. Jansson L., Holmdahl R. Estrogen-mediated immunosuppression in autoimmune diseases. Inflamm Res 1998, 47:290-301.
74. Persellin R.H. The effect of pregnancy on rheumatoid arthritis. Bull Rheum Dis 1976, 27:922-927.
75. Silman A., Kay A., Brennan P. Timing of pregnancy in relation to the onset of rheumatoid arthritis. Arthritis Rheum 1992, 35:152-157.
76. Santner-Nanan B., Peek M.J., Khanam R., et al. Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia. J Immunol 2009, 183:7023-7030.
77. Lee T.P., Chiang B.L. Sex differences in spontaneous versus induced animal models of autoimmunity. Autoimmun Rev 2012, 11:A422-A429.
78. Confavreux C., Vukusic S., Adeleine P. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 2003, 126:770-782.
79. Luchetti S., van Eden C.G., Schuurman K., et al. Gender differences in multiple sclerosis: induction of estrogen signaling in male and progesterone signaling in female lesions. J Neuropathol Exp Neurol 2014, 73:123-135.
80. Pozzilli D., Tomassini V., Marinelli F., et al. "Gender gap" in multiple sclerosis: magnetic resonance imaging evidence. Eur J Neurol 2003, 10:95-97.
81. Robel P., Baulieu E.E. Neurosteroids: biosynthesis and function. Crit Rev Neurobiol 1995, 9:383-394.
82. Garcia-Ovejero D., Azcoitia I., Doncarlos L.L., et al. Glia-neuron crosstalk in the neuroprotective mechanisms of sex steroid hormones. Brain Res Brain Res Rev 2005, 48:273-286.
83. Yates M.A., Li Y., Chlebeck P., et al. Progesterone treatment reduces disease severity and increases IL-10 in experimental autoimmune encephalomyelitis. J Neuroimmunol 2010, 220:136-139.